EyePoint Pharmaceuticals Inc’s (PV3B) Moving Averages Convergence Divergence (MACD) indicator is -0.50, suggesting EyePoint Pharmaceuticals Inc is a Buy.

EyePoint Pharmaceuticals Inc’s (PV3B) 20-Day exponential moving average is 8.46, while EyePoint Pharmaceuticals Inc’s (PV3B) share price is €7.528, making it a Sell.

EyePoint Pharmaceuticals Inc’s (PV3B) 50-Day exponential moving average is 8.91, while EyePoint Pharmaceuticals Inc’s (PV3B) share price is €7.528, making it a Sell.

EyePoint Pharmaceuticals (PV3B) Pivot Points

Jan 02, 2025, 09:34 AM

Classic

7.47

7.54

7.67

7.74

7.87

7.93

8.07

Fibonacci

7.54

7.61

7.66

7.74

7.81

7.86

7.93

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

EyePoint Pharmaceuticals (PV3B) Moving Averages

Jan 02, 2025, 09:34 AM

MA5

8.00Sell

7.86Sell

MA10

8.04Sell

8.06Sell

MA20

8.25Sell

8.46Sell

MA50

9.45Sell

8.91Sell

MA100

8.60Sell

9.39Sell

MA200

11.07Sell

12.40Sell

EyePoint Pharmaceuticals Inc’s (PV3B) 10-Day exponential moving average is 8.06, while EyePoint Pharmaceuticals Inc’s (PV3B) share price is €7.528, making it a Sell.

EyePoint Pharmaceuticals Inc’s (PV3B) 100-Day exponential moving average is 9.39, while EyePoint Pharmaceuticals Inc’s (PV3B) share price is €7.528, making it a Sell.

EyePoint Pharmaceuticals Inc’s (PV3B) stock price is €7.528 and EyePoint Pharmaceuticals Inc’s (PV3B) 50-day simple moving average is 9.45, creating a Sell signal.

EyePoint Pharmaceuticals Inc’s (PV3B) stock price is €7.528 and EyePoint Pharmaceuticals Inc’s (PV3B) 100-day simple moving average is 8.60, creating a Sell signal.

EyePoint Pharmaceuticals Inc’s (PV3B) stock price is €7.528 and EyePoint Pharmaceuticals Inc’s (PV3B) 200-day simple moving average is 11.07, creating a Sell signal.

EyePoint Pharmaceuticals (PV3B) Technical Indicators

Jan 02, 2025, 09:34 AM

RSI (14)

36.29

Neutral

STOCH (9,6)

31.36

Neutral

STOCHRSI (14)

25.63

Neutral

MACD (12,26)

-0.50

Buy

ADX (14)

25.07

Neutral

Williams %R

-92.19

Buy

CCI (14)

-160.13

Buy

ATR (14)

0.47

Ultimate Oscillator

57.49

Neutral

ROC

-13.17

Sell

EyePoint Pharmaceuticals Inc’s (PV3B) Relative Strength Index (RSI) is 36.29, creating a Neutral signal.

EyePoint Pharmaceuticals Inc’s (PV3B) Trend Strength Indicator (ADX) is 25.07, creating a Neutral signal.

EyePoint Pharmaceuticals Inc’s (PV3B) Commodity Channel Index (CCI) is -160.13, creating a Buy signal.

EyePoint Pharmaceuticals Inc’s (PV3B) Price Rate of Change (ROC) is -13.17, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is PV3B a Buy, Hold, or Sell?

Based on PV3B’s technical indicators, PV3B is a Strong Sell.

What is PV3B’s RSI (14)?

PV3B’s RSI (14) is 36.29, which suggests PV3B is a Neutral.

What is PV3B’s MACD?

PV3B’s MACD is -0.50, which suggests PV3B is a Buy.

What is PV3B’s 5-day moving average?

PV3B’s 5-day moving average is 8.00, which suggests PV3B is a Sell.

What is PV3B’s 20-day moving average?

PV3B 20-day moving average is 8.25, which suggests PV3B is a Sell.

What is PV3B’s 50-day moving average?

PV3B’s 50-day moving average is 9.45, which suggests PV3B is a Sell.

What is PV3B’s 200-day moving average?

PV3B’s 200-day moving average is 11.07, which suggests PV3B is a Sell.

What is PV3B’s Williams % R (14)?

PV3B’s Williams % R (14) is -92.19, which suggests PV3B is a Buy.

What is PV3B’s CCI (14)?

PV3B’s CCI (14) is -160.13, which suggests PV3B is a Buy.

What is the share price of EyePoint Pharmaceuticals Inc?

EyePoint Pharmaceuticals's share price is 7.53€.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing